Malignant transformation of mouse skin by chemical carcinogens and tumor promoters, such as the phorbol ester 12-O-tetradecanoylphorbol-13-acetate, is a multistage process leading to the formation of squamous cell carcinomas. In an effort to identify target genes whose expression is associated with skin tumorigenesis we combined elements of suppression subtractive hybridization with differential screening to isolate genes that are differentially upregulated in mouse skin after short-term treatment with 12-Otetradecanoylphorbol-13-acetate and that exhibit a high constitutive expression in squamous cell carcinomas. Here, we report the detailed analysis of one of these cDNAs encoding the serine protease BSSP in mouse skin. Phorbol ester application increases BSSP expression in keratinocytes of the epidermis and the hair follicle several-fold starting 4 h posttreatment. Transcriptional activation of BSSP by 12-O-tetradecanoylphorbol-13-acetate was found to be independent of c-Fos expression and resistant to downregulation by glucocorticoids. By monitoring BSSP expression throughout experimental skin carcinogenesis we found strong constitutive expression in hyperplastic epidermis as well as in proliferatively active keratinocytes of benign and malignant skin tumors. These results establish a novel link between expression of an as yet ill-de®ned serine protease and skin carcinogenesis. Key words: AP-1/epidermis/ multistage skin carcinogenesis/tumor promoter/suppression subtraction hybridization. J Invest Dermatol 117: 634±640, 2001 T umorigenesis represents a complex multistage process in which genetic changes and environmental factors are thought to deregulate the cellular processes that control cell proliferation and differentiation. To provide reliable diagnostic markers and to develop novel therapeutic avenues for cancer treatment an understanding of the molecular basis of skin tumors, as well as other cancer types, will be essential, particularly the identi®cation and functional characterization of cellular genes that are targeted by oncogenic stimuli.
One class of transcription factors that mediates gene regulation in response to radiation, chemical carcinogens, tumor promoters, and oncoproteins is the activator protein 1 (AP-1) family (Angel and Karin, 1991) . AP-1 represents a plethora of dimeric complexes composed of members of Jun, Fos, and ATF proteins. Gain-offunction approaches, both in tissue culture cells and in mice, have established the ability of Jun and Fos to induce cell transformation upon overexpression. Furthermore, ®broblasts lacking Fos or Jun proteins cannot be transformed by oncoproteins, such as Ras and Src (Angel and Karin, 1991; Wisdom, 1999) . Most importantly, AP-1 subunits have been proven to contribute to premalignant conversion and malignant progression of epidermal cells in the initiation-promotion protocol of mouse multistage skin carcinogenesis, which ranks among the best studied in vivo approaches in experimental cancer research (Greenhalgh et al, 1990; Dong et al, 1994; Yuspa et al, 1994; Brown and Balmain, 1995; Joseloff and Bowden, 1997) . In particular, in mice lacking c-fos the development of malignant skin tumors from papillomas is blocked at the transition from the benign to the malignant state (Saez et al, 1995) . Moreover, transgenic mice expressing a transdominant-negative version of c-Jun (TAM67) are resistant to 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) induced skin tumorigenesis (Young et al, 1999) .
The critical role of AP-1 in skin carcinogenesis is also supported by the increased expression level of two``classical'' AP-1 target genes, stromelysin-1/matrix metalloproteinase 3 (MMP-3) and collagenase-3/MMP-13, in squamous cell carcinoma (SCC) (D'Armiento et al, 1995; Sternlicht et al, 1999; Tuckermann and Breitenbach, unpublished) . In line with these data, expression of both genes can be rapidly induced more than 100-fold in mouse skin upon treatment with the phorbol ester TPA (Tuckermann et al, 1999) . Interestingly, cotreatment of mouse skin with glucocorticoids blocks both phorbol-ester-mediated multistage carcinogenesis (Slaga, 1984; Budunova et al, 1997) and transcriptional upregulation of MMP-3 and MMP-13 in skin, possibly by mutual interference between the glucocorticoid receptor and AP-1 (Karin, 1998; Tuckermann et al, 1999) . In addition to AP-1, however, other transcription factors that synergize with AP-1, such as NFkB (Stein et al, 1993) , become activated in skin by TPA (Budunova et al, 1999) , suggesting that genetic programs regulated directly or indirectly by AP-1, as well as AP-1-independent target genes, contribute to the process of skin carcinogenesis.
In order to identify novel genes that may contribute to neoplastic skin growth we used suppression subtraction hybridization (SSH) to create a library of TPA-inducible genes in mouse skin. These cDNA clones were characterized by reverse northern blot analysis using complex cDNA probes derived from SCC to select for genes that exhibit high basal level expression at late stages of skin carcinogenesis.
In this study, we report the detailed analysis of a newly identi®ed TPA-inducible cDNA clone, identical to the 3¢ end of a recently described serine protease BSSP expressed in murine brain and skin (Meier et al, 1999) . We observed high levels of BSSP transcripts after phorbol ester treatment of murine skin and throughout the multistage carcinogenesis process in skin, relative to untreated control tissue. These data suggest that BSSP may be involved in the process of skin carcinogenesis by virtue of its serine protease activity involved directly or indirectly in the alteration of the local environment to support tumor cell growth and invasion.
MATERIALS AND METHODS
Animals Female C57BL/6 mice aged 7±9 wk and female NMRI mice (RCC, Fu Èllinsdorf, Switzerland) as well as c-fos ±/± mice (Wang et al, 1992) were housed in speci®c pathogen free and light, temperature (21°C), and humidity (50%±60% relative humidity) controlled conditions. Food and water were available ad libitum. The procedures for performing animal experiments were in accordance with the principles and guidelines of the ATBW (of®cials for animal welfare) and were approved by the Regierungspra Èsidium Karlsruhe.
Treatment of mouse skin C67BL/6 and c-Fos ±/± mice as well as their littermates were shaved on the dorsal skin and treated 3 d later topically with 10 nmol TPA, which is the dose used for the promotion of skin tumors (Marks and Fu Èrstenberger, 1990) , or with 10 nmol TPA plus 50 mg dexamethasone (Sigma Chemical) dissolved in 200 ml acetone. The animals were sacri®ced 0±16 h after TPA application. Hyperplastic skin was obtained from female NMRI mice. Three days before start of treatment 7-wk-old animals were shaved; subsequently, for a period of 7 wk single doses of 10 nmol TPA were dissolved in acetone and applied twice a week onto the dorsal skin. Four days after the last TPA application the animals were sacri®ced and the skin was taken. Skin tumors derived from female NMRI mice used in this study were generated according to the initiation-promotion protocol of chemically induced multistage carcinogenesis (Fu Èrstenberger and Kopp-Schneider, 1995) . All tissues and tumors were isolated and immediately frozen in liquid nitrogen.
Isolation of poly(A) + RNA and cDNA synthesis Total RNA was isolated from acetone-control skin and 6 h TPA-treated mouse dorsal skin using RNeasy (AGS, Heidelberg, Germany) according to the manufacturer's recommendation. Poly(A) + RNA was puri®ed using oligo(dT) coated Quiaex beads (Quiagen, Hilden, Germany). To synthesize double-stranded cDNA aliquots of 2 mg poly(A) + RNA with 500 ng oligo(dT)-RsaI primer adapter (Clontech, Palo Alto, CA) in a volume of 11 ml were heated to 70°C for 10 min in a thermal cycler (Perkin Elmer 2400) and rapidly chilled on ice. The reaction mixture was made up to 20 ml by adding 4 ml 5 Q ®rst-strand buffer (provided with the Superscript reverse transcriptase; Gibco BRL, Karlsruhe, Germany), 2 ml 0.1 M dithiothreitol, and 1 ml dNTP mix (10 mM each dATP, dGTP, dCTP, and dTTP). Reverse transcription was started by adding 2 ml reverse transcriptase and incubating for 1 h. Subsequently, Klenow-mediated second-strand cDNA synthesis was performed according to the instructions of the PCR-SelectÔ cDNA subtraction kit (Clontech).
Generation of a subtracted library using SSH SSH was performed between cDNA from acetone-control skin (``tester'') and 6 h TPAtreated mouse dorsal skin (``driver'') using the PCR-Select cDNA subtraction kit (Clontech) according to the manufacturer's recommendation, except for modi®cations of the polymerase chain reaction (PCR) and hybridization conditions. All PCR and hybridization steps were performed on a Perkin Elmer 2400 thermal cycler. For the ®rst hybridization the mixture of``driver'' and``tester'' cDNAs was denatured at 100°C for 20 s and then cooled over 1 min to 68°C and maintained at this temperature for 8 h. For the second hybridization, a 2-fold excess of control``driver'' cDNA (von Stein et al, 1997) was denatured at 100°C for 20 s and then added directly to the pooled mix of the two previous hybridizations and allowed to incubate at 68°C for 20 h. It was necessary to alter the PCR conditions (see below) such that the ampli®cation of unaltered sequences was kept to a minimum. All other procedures for generation of the subtracted library were done according to the guidelines of the cDNA subtraction kit. PCR parameters were as follows: 20 cycles of 94°C for 20 s, 68°C for 30 s, and 72°C for 2 min. The subtracted cDNA was subjected to a second round of PCR (nested), using the same PCR conditions with the exception that 14 cycles were performed. The subtracted cDNA library was cloned directly into the T/A vector pCRII.1 (TA cloning kit, Invitrogen, De Schelp, Netherlands) and the ligation was transformed into Electromax bacterial strain DH10B (Life Science, Karlsruhe, Germany).
Reverse northern high density blot analysis A total of 3000 individual recombinant clones were picked and individually inoculated into sterile 96-well microtiter plates containing LB-medium and ampicillin at 100 mg per ml. After incubation of bacteria on a gyratory shaker for 8 h at 37°C, equal amounts of the liquid cultures were spotted in duplicate onto nylon membranes (Hybond N + , Amersham Pharmacia, Freiburg, Germany). The ®lters were hybridized under stringent conditions (7% sodium dodecyl sulfate in 0.5 M NaPO 4 , pH 7.2) at 65°C overnight with equivalent amounts of 32 P-labeled double-stranded cDNA probes derived from acetone-control``driver'' and 6 h TPAtreated murine dorsal skin``tester'' mRNA, respectively, which were prepared according to the recommendation of Roche Diagnostics' cDNA synthesis kit (Roche Diagnostics, Mannheim, Germany). Filters were washed under stringent conditions at 65°C. The ®lters were exposed to X-ray ®lm up to 2 d at ±80°C and the signals of corresponding clones were compared. The complex``driver'' and`t ester'' cDNA probes were also used for southern blot analysis of EcoRI-digested plasmid of selected cDNA clones.
Northern blot analysis Total RNA was isolated from cell lines, from 6 h acetone-control, TPA-treated, and TPA-plus-dexamethasone-treated murine skin, and from SCC, as described previously (Tuckermann et al, 1999) . Fifteen micrograms total RNA were fractionated on 1.4% formaldehyde-agarose gels and subjected to northern blot analysis using an [a-32 P]dCTP-labeled BSSP cDNA insert (nucleotides 608±1095 of the published BSSP sequence; Meier et al, 1999) , which was isolated by EcoRI digestion of the appropriate pCRII.1-plasmid. The probe for 18S rRNA was obtained by reverse transcription PCR using RNA from mouse skin.
In situ hybridization In situ hybridization was performed on 6 mm paraf®n sections as described in detail previously (Gack et al, 1995) . All the samples were ®xed in 4% paraformaldehyde and treated with proteinase K (0.3 mg per ml); subsequently they were washed in 0.1 M triethanolamine buffer containing 0.25% acetic anhydride. The sections were covered with 20±100 ml of hybridization buffer containing 1.5 Q 10 6 cpm of 35 S-labeled antisense or sense RNA probe, and incubated at 53°C for 18 h in a humidi®ed chamber. After hybridization, the slides were washed under stringent conditions (50% formamide, 65°C), including treatment with RNAse A (20 mg per ml) to remove unhybridized probe. After 7±21 d of autoradiography, the photographic emulsion (NTB2; Kodak, Mu Ènchen, Germany) was developed, and the slides were stained with hematoxylin and eosin. Each sample was hybridized in at least two experiments. BSSP cRNA probe was derived by in vitro transcription from a HindIII linearized recombinant plasmid pCRII.1 containing a 487 bp fragment (nucleotides 608±1095 of the published BSSP sequence; Meier et al, 1999) . As a control for nonspeci®c hybridization, sections were hybridized with 35 S-labeled sense RNA from the pCRII.1 plasmid linearized with BamHI.
Immunohistochemistry Six micron thick paraf®n sections from skin biopsies were treated as described previously (Schnarr et al, 2000) followed by incubation with anti-proliferative cellular nuclear antigen (anti-PCNA) antibodies (10 mg per ml ®nal concentration; DAKO, Hamburg, Germany) for 16 h at 4°C. After thorough rinsing with 50 mM Tris-buffer (pH 7.4) sections were incubated with 18 mg per ml goat antirabbit IgG (Dianova, Hamburg, Germany) followed by two cycles of incubation with a 1:10 diluted mouse alkaline phosphatase± antialkaline phosphatase complex (APAAP; Linaris, Mu Ènchen, Germany). After washing with distilled water for 5 min, sections were incubated with naphthol AS-BI phosphate (Sigma, Mu Ènchen, Germany) as substrate and stained with fuchsin (Sigma) as chromogen. Blocking of the endogenous alkaline phosphatase was achieved by adding 1.73 mM levamisol (Sigma).
RESULTS
Cloning of phorbol-ester-inducible genes from mouse skin Recently, we established in vivo conditions to induce rapid alterations in gene expression of the well-known AP-1 target genes MMP-3 and MMP-13 in mouse skin by phorbol esters (Tuckermann et al, 1999) . In order to identify novel phorbolester-inducible genes we used this experimental set-up to apply SSH using poly(A) + RNA from murine skin 6 h after treatment with TPA. Three thousand clones of the generated subtractive library were spotted onto nylon membranes. Comparative hybridization analysis identi®ed 400 clones highly upregulated in TPA-treated mouse skin (data not shown; examples of a rehybridization of selected clones are shown in Fig 1) . These cDNAs were derived from 76 unique known and 25 unknown genes. To select for TPA-inducible genes highly expressed at late stages of carcinogenesis, reverse northern blot hybridization using a complex cDNA probe derived from pooled SCC was performed. As shown in Fig 1, some of the TPA-inducible genes, such as metallothionein Ia (lane 7), did not exhibit enhanced expression in SCC. This additional screening procedure led to the identi®cation of ®ve unknown cDNAs, which are derived from genes that are highly expressed in SCC. Moreover, 29 cDNAs of known genes were isolated including established AP-1-regulated genes, such as the virus-like retrotransposon VL30 (Fig 1, lane 3) or the small proline rich protein (SPRR) 1A (data not shown). VL30 and SPRR1A have been previously documented to be overexpressed in SCC (French and Norton, 1997; Tesfaigzi and Carlson, 1999) . One of these clones (Fig 1, lane 15 ) was found to be identical to the 3¢ end of the recently described serine protease BSSP (Meier et al, 1999) . As this gene has not yet been associated with the process of skin carcinogenesis, and in light of the proposed function of members of the protein family of serine proteases, this clone was chosen for further analysis.
Regulation of BSSP expression in TPA-treated mouse skin To examine the time course of phorbol-ester-mediated transcriptional activation of BSSP, mouse skin was treated with TPA for different time periods. Northern blot analysis revealed a strong increase in the abundance of the 1.3 kb BSSP message detectable 4 h after treatment reaching maximal levels 12±16 h post-stimulation (Fig 2 and data not shown) , resembling the expression pro®le described for known AP-1 target genes such as MMP-3 and MMP-13 in mouse skin (Tuckermann et al, 1999) .
In order to analyze the importance of the AP-1 transcription factor in TPA-induced BSSP expression, BSSP mRNA levels were compared between mice de®cient in one major member of AP-1 subunits, c-Fos (Wang et al, 1992) , and their wild-type littermates. As shown in Fig 3 (right panel) the basal level of BSSP expression was even slightly increased in c-fos ±/± mice and the application of TPA onto the skin of these animals led to a strong increase in the abundance of the BSSP mRNA, similar to the increase observed in their wild-type littermates. These data show that c-Fos expression is dispensable for phorbol-ester-induced upregulation of BSSP in skin.
Glucocorticoids are known to block experimentally induced tumorigenesis, such as phorbol-ester-mediated multistage carcinogenesis in mouse skin (Belman and Troll, 1972) . To investigate if glucocorticoids in¯uence the phorbol-ester-mediated transcriptional activation of the BSSP gene in vivo, TPA-induced expression in skin was analyzed in the presence of the synthetic glucocorticoid dexamethasone. Concomitant glucocorticoid treatment did not alter the level of BSSP expression induced by TPA in wild-type and c-Fos-de®cient mice indicating that glucocorticoids do not transrepress the activation of the BSSP gene in mouse skin (Fig 3,  left panel) .
Expression of BSSP in interfollicular epidermis and hair follicle In order to identify the speci®c cell types in the skin responsible for enhanced BSSP gene expression in response to Filters were hybridized with single-stranded 32 P-labeled complex cDNA probes of equal speci®c activity obtained from acetone-control (co) or 6 h TPA-treated (TPA) dorsal skin (n = 3) as well as from SCC (SCC; n = 8). VL30, virus-like retrotransposon; MTI, metallothionein Ia; BSSP, brain and skin speci®c serine protease. Expressions of the housekeeping genes GAPDH and COX were used as internal controls for hybridization. Figure 2 . BSSP expression in TPA-treated mouse skin. After 0 (co), 1, 2, 4, 6, and 12 h TPA-treated mice were sacri®ced and total RNA from skin was isolated as described in Materials and Methods. BSSP expression was analyzed by northern blot hybridization using the isolated SSH fragment as a probe. Each lane represents RNA pooled from three individuals. Rehybridization with a cDNA fragment of 18S RNA was performed, serving as a loading control. TPA, in situ hybridization analysis on transversal sections of skin biopsies was performed. In untreated skin speci®c signals for BSSP expression were not detectable either in the interfollicular epidermis ( Fig 4A) or in the hair follicle (Fig 4B) , whereas a signi®cant increase in epidermal BSSP expression in epithelial cells became visible upon phorbol ester treatment ( Fig 4C) . Upon TPA treatment BSSP transcripts were also observed in keratinocytes of the hair follicles but not in ®broblasts of the dermis (Fig 4D) . In line with the expression pattern determined by northern blot analysis the simultaneous application of dexamethasone did not affect TPA-induced BSSP expression in murine skin, as shown in Figs 4(E), 4(F) . Analysing the cell-type-speci®c expression of BSSP in the skin of mice de®cient for c-Fos, no difference in localization or strength of BSSP between wild-type and mutant littermates (data not shown) was detectable, con®rming the results obtained by northern blot hybridization (Fig 3) .
Expression
of BSSP during multistage skin carcinogenesis As we found enhanced levels of BSSP transcripts in RNA from SCC (Fig 1) , we examined the sites of BSSP expression during different stages of skin carcinogenesis by in situ hybridization analysis. In hyperplastic skin, induced by chronic treatment with TPA, BSSP expression was found predominantly in the basal compartment of the hyperplastic epidermis 4 d after the ®nal TPA application (Figs 5A, B) . This layer is characterized by a high proliferative activity as visualized by staining for PCNA ( Fig 5C) . Expression was also found in hair follicles (data not shown). In chemically induced papillomas the strongest expression of BSSP transcripts was also detected in the proliferatively active basal cell layer ( Fig 5D±F) . Finally, in malignant SCC high levels Figure 4 . Tissue-speci®c expression of BSSP in murine dorsal skin. Acetone (A, B) , TPA (C, D), as well as TPA plus dexamethasone (E, F) were applied onto the skin of adult female C57BL/6 mice. After 6 h mice were sacri®ced; skin biopsies were taken, paraformaldehyde-®xed and subsequently paraf®n-embedded. The SSH-derived cDNA clone of BSSP was 35 S-labeled and used as a riboprobe for in situ hybridization. BSSP expression can be detected in keratinocytes of the epidermis (ep) and hair follicle (hf), but not in ®broblasts of the dermis (de; arrows). Scale bar: 20 mm. c-fos-de®cient mice (fos ±/± ) and their wild-type littermates (fos +/+ ) were treated with acetone (co), 10 nmol TPA (TPA), or 10 nmol TPA with 50 mg dexamethasone (T + D). After 6 h mice were sacri®ced and total RNA from skin was isolated as described in Materials and Methods. BSSP expression was analyzed by northern blot hybridization using the isolated SSH fragment as a probe. Each lane represents RNA pooled from three individuals. Rehybridization with a cDNA fragment of 18S RNA was performed, serving as a loading control.
of BSSP transcripts were detected in keratinocytes at the edge of proliferative carcinoma cell islets ( Fig 5G±I) .
DISCUSSION
In the well-characterized murine skin carcinogenesis model phorbol esters such as TPA belong to the most potent tumor promoters (Marks and Furstenberger, 1990) . Tumorigenesis represents a complex process in which aberrant expression of cellular genes plays a decisive role. Until now, however, only very few TPA-inducible genes that are critically involved in skin tumor formation and metastasis, such as mal1 (Krieg et al, 1993) , transin (Matrisian et al, 1986) , MMP-9 (Coussens et al, 2000) , CD44 (Herrlich et al, 1995) , and urokinase plasminogen activator (Yu and Stamenkovic, 1999) , have been identi®ed. Using a combination of SSH between control and short-term TPA-treated murine skin with subsequent screening by reverse northern blot hybridization we have isolated several known as well as unknown cDNAs, representing TPA-inducible genes, which are constitutively expressed at a late stage of carcinogenesis.
As the ®rst example of a candidate gene obtained by this fruitful experimental strategy, here we describe the phorbol-ester-induced expression of BSSP in murine skin. Although BSSP has been previously described to be exclusively expressed in hair follicles of nude mice (Meier et al, 1999) as well as in murine brain (Matsui et al, 2000) , we report here a tumor-associated expression of this serine protease throughout the process of carcinogenesis in mouse skin.
The transcription factors mediating BSSP activation in tissue culture cells and in the animal have not yet been identi®ed. Our data document transcriptional activation of BSSP upon short-term treatment with the protein kinase C activator TPA, starting 4 h after TPA treatment. The kinetics of BSSP induction resemble the expression pro®les of MMP-3 and MMP-13 (Tuckermann et al, 1999) , which are known to be transcriptionally regulated by AP-1 (Hu et al, 1994; Kolbus et al, 2000) . Moreover, the BSSP promoter contains a consensus binding site for AP-1 at position ±992 to ±998 relative to the putative transcriptional start site (Matsui et al, 2000) . No reduction of phorbol-ester-mediated transcriptional activation of BSSP in skin was observed in c-Fos-de®cient mice, however, which might argue against a critical role of AP-1 in transcriptional regulation of BSSP. On the other hand it is also possible that other members of the AP-1 family, which are expressed in the skin (Welter and Eckert, 1995; Rutberg et al, 1996; Schorpp-Kistner and Angel, unpublished) , functionally compensate for the loss of c-Fos. Alternatively, induction might be mediated by other TPAinducible transcription factors, such as NFkB (Nelsen et al, 1988) , which was found to exhibit high basal level activity in many late papillomas and SCC (Budunova et al, 1999) . The available sequence of the BSSP promoter described by Matsui et al (2000) , however, does not harbour NFkB binding sites. Therefore, a detailed analysis of deletion and point mutants of the BSSP promoter will be required to identify the critical cis-acting elements responsible for TPA-mediated transcriptional activation.
Although in untreated skin we and colleagues (Meier et al, 1999) found BSSP levels to be below the level of detection, treatment of skin with TPA for 6 h induced the expression of BSSP in keratinocytes of the interfollicular epidermis and hair follicles. Interestingly, a hair-follicle-speci®c expression of BSSP was reported in nude mice (Meier et al, 1999) , which carry a loss-offunction mutation in the whn gene. This gene encodes a sequence-speci®c DNA binding protein, which is speci®cally expressed in hair follicles (Lee et al, 1999) . It is tempting to speculate that TPA might exert its effect on BSSP expression, at least in the keratinocytes of the hair follicle, by deactivating a Whn-mediated inhibition of BSSP expression.
By virtue of reverse northern blot and in situ hybridization we could document a high constitutive level expression of BSSP in SCC of the skin. This massive increase of BSSP transcripts was observed throughout hyperplastic, benign, as well as malignant stages of this epithelial tumorigenesis model. As BSSP transcripts were not detectable in untreated murine skin these data may suggest a role of BSSP in tumorigenesis. Similar ef®ciency of TPAdependent, glucocorticoid-insensitive induction of BSSP in wildtype and c-Fos-de®cient mice may argue against this hypothesis. It is important to note that these criteria do not strictly select for tumor-associated genes, however, because wild-type and mutant mice do not differ in early stages of tumorigenesis, such as hyperplasia and formation of papillomas (Saez et al, 1995) . On the other hand, established skin papillomas and SCC become resistant to growth inhibition by glucocorticoids through downmodulation of the glucocorticoid receptor (Budunova et al, 1997) . Most probably, tumorigenesis is a multifactorial process, where products of AP-1-dependent and AP-1-independent genes functionally interact in an interdependent manner and loss of expression of genes from either category might interfere with tumorigenesis.
The predicted BSSP protein sequence indicates that BSSP is a secreted kallikrein-like protease, showing highest homology to human protease M, isolated from primary breast cancer cell lines (Anisowicz et al, 1996; Meier et al, 1999) . As reported for other members of the kallikrein subfamily of serine proteases, namely prostatic speci®c antigen and normal epithelial cell speci®c 1 gene, which are speci®cally expressed in various cancer tissues (Diamandis et al, 2000) , human protease M is found to be overexpressed in ovarian cancer and the colon carcinoma cell line COLO 201 (Yousef et al, 1999) . As expression or activities of several proteases, such as cathepsin D, plasminogen activator, stromelysin-1/MMP-3, and gelatinase B/MMP-9, were found to correlate with tumorigenic progression, particularly in breast and skin tumors (Basset et al, 1990; Liotta and Stetler-Stevenson, 1991; Sternlicht et al, 1999; Coussens et al, 2000) , the cloning of the human BSSP homolog and functional analysis of BSSP in various tumor models merits enhanced effort. Proteinases play pivotal roles in altering local microenvironments under physiologic and pathologic conditions (formation and remodeling of extracellular matrix, angiogenesis, and vasculogenesis; Lochter et al, 1998; Vu and Werb, 2000) . Moreover, BSSP, as shown for many other proteases, may participate in the activation of hormones and growth factors by proteolytic cleavage of inactive proforms (Matrisian and Hogan, 1990) .
Nonmelanoma skin cancers are known to arise from the transformation of basal keratinocytes either of the interfollicular epidermis or of the hair follicle (Taylor et al, 2000) . Whereas in untreated murine skin BSSP mRNA was not detectable, we observed constitutive BSSP expression not only in keratinocytes of hyperplastic skin, malignant tumors, and papillomas, but also after a single treatment with the tumor promoter TPA in keratinocytes of the interfollicular epidermis as well as in the hair follicle, indicating a role of BSSP already in the early stages of the tumorigenic process. Interestingly, in a keratinocyte cell line isolated from DMBAinitiated skin (MCA 3D) TPA faintly induces the expression of BSSP transcripts, and in cell derivatives expressing an oncogenic version of Ras (MCA AT3) both basal and TPA-induced levels are further increased (data not shown).
Furthermore, we found a massive expression of BSSP at late stages of the tumorigenesis process in skin. The restriction of BSSP expression to proliferatively potent basal keratinocytes at the front of carcinoma cell islets in skin is intriguing and suggests a direct or indirect function of this protease in the proteolytic cascade leading to degradation of the extracellular matrix. In accordance with this idea recombinantly expressed BSSP was shown to degrade ®bronectin and gelatine (Matsui et al, 2000) . In light of the proposed function of BSSP in the extracellular space (Meier et al, 1999) it is tempting to speculate that BSSP may also contribute to the invasive and metastatic potential of tumor cells.
The characterization of BSSP as a serine protease expressed throughout the process of skin carcinogenesis adds another member to a group of kallikrein-like proteases that may participate in a cascade mechanism of enzymatic reactions resulting in the degradation of extracellular matrix components or liberation of bioactive peptides or polypeptides. Based on its structural characteristics and expression pattern in cancer tissues it will be important to precisely de®ne the role of BSSP in cell transformation, angiogenesis, tumor progression, and invasion. These data, together with the identi®cation of BSSP activators and targets, may help to establish BSSP as a diagnostic or therapeutic target for the treatment of at least skin cancer.
